OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.550
+0.030 (1.97%)
Mar 13, 2026, 4:00 PM EDT - Market closed
OS Therapies Market Cap
OS Therapies has a market cap or net worth of $54.58 million as of March 13, 2026. Its market cap has increased by 56.71% in one year.
Market Cap
54.58M
Enterprise Value
52.71M
1-Year Change
56.71%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on August 1, 2024, OS Therapies's market cap has increased from $50.32M to $54.58M, an increase of 8.46%. That is a compound annual growth rate of 5.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 54.58M | 10.71% |
| Dec 31, 2025 | 49.30M | -45.76% |
| Dec 31, 2024 | 90.90M | 80.63% |
| Aug 1, 2024 | 50.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 59.13M |
| Metagenomi Therapeutics | 59.06M |
| NRx Pharmaceuticals | 57.37M |
| Edesa Biotech | 53.26M |
| Radiopharm Theranostics | 53.23M |
| Kezar Life Sciences | 52.87M |
| Estrella Immunopharma | 52.54M |
| Plus Therapeutics | 52.13M |